Docket #: S06-455
Monoclonal Antibody against human LMO2 Antigen
This antibody is directed against the human LMO2 antigen, which is expressed as a transcription factor in certain lymphomas and leukemias. We have recently shown that it identifies those lymphomas derived from germinal center B cells. These lymphomas are the subset with a better response to therapy and a better prognosis.
LMO2 gene translocations have been found in a subset of human T cell acute leukemias.
The LMO2 gene was a site of specific integration of gene therapy vectors which caused leukemia.
Applications
- Useful in classification of human lymphoma and leukemia.
- Useful in establishing prognosis in human lymphoma and leukemia
Similar Technologies
-
HLA-A clone, A11.1M (ATCC HB-164) S20-494HLA-A clone, A11.1M (ATCC HB-164)
-
Deriving human induced pluripotent stem cells from pre-exposed fibroblasts S22-495Deriving human induced pluripotent stem cells from pre-exposed fibroblasts
-
Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7 S83-007Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7